We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Transfusion in Sickle Cell Disease: Risk Factors for Alloimmunization

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03405402
Recruitment Status : Completed
First Posted : January 23, 2018
Last Update Posted : January 28, 2021
Information provided by (Responsible Party):
Hanane EL KENZ, Brugmann University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 3, 2020
Actual Study Completion Date : August 3, 2020